Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

After health reform, Lilly looking for more
Indianapolis Business Journal, IN
Wednesday, September 1, 2010 - 11:44am
tags:
healthcare reform, Eli Lilly
Pfizer Files Suit Against Mylan
TheStreet.com
Wednesday, September 1, 2010 - 11:39am
tags:
Pfizer, Mylan, Chantix, generics, smoking cessation
Allergan to pay $600 million to settle Department of Justice probe into Botox marketing
Yahoo/AP
Wednesday, September 1, 2010 - 11:38am
tags:
Allergan, DOJ, Botox, settlements, off-label
Sanofi Will Gobble Up Genzyme: Big Investors
Pharmalot
Wednesday, September 1, 2010 - 9:00am
tags:
Genzyme, Sanofi, M&A
Pfizer buying FoldRx for undisclosed amount
Yahoo/AP
Wednesday, September 1, 2010 - 8:52am
tags:
FoldRx, M&A, Pfizer
Pipeline Review: Bristol-Myers Squibb's 5 Keys to Success
Motley Fool
Wednesday, September 1, 2010 - 8:51am
tags:
Bristol-Myers Squibb, Plavix, generics
AstraZeneca Given More Time to Settle 6,000 Seroquel Cases Before Trials
Bloomberg
Wednesday, September 1, 2010 - 8:10am
tags:
settlements, AstraZeneca, Seroquel, antipsychotics
Immunogen: What Really Happened With T-DM1’s Filing?
Seeking Alpha
Wednesday, September 1, 2010 - 8:08am
tags:
Immunogen, Ranbaxy, breast cancer
Dendreon: Medicare Coverage Fears Allayed
TheStreet.com
Wednesday, September 1, 2010 - 8:07am
tags:
Dendreon, Medicare, Provenge, prostate cancer
Genzyme Sale Inevitable, Buysiders Say
TheStreet.com
Wednesday, September 1, 2010 - 7:24am
tags:
Genzyme, M&A, Sanofi, GSK, Pfizer, JNJ
Drugmakers May Lose a Back Door for Drug Approval
Motley Fool
Wednesday, September 1, 2010 - 6:48am
tags:
FDA, drug approvals
Allergan says FDA approved new version of Lumigan for treating conditions related to glaucoma
Yahoo/AP
Wednesday, September 1, 2010 - 6:47am
tags:
Allergan, glaucoma, FDA, Lumigan
5 Drugmakers With Killer Dividends
Motley Fool
Wednesday, September 1, 2010 - 6:46am
tags:
dividends, Pfizer, Merck, JNJ, Eli Lilly, Bristol-Myers Squibb
The Dangers Of Information Restrictions On Drugs’ Off-Label Uses
Forbes
Tuesday, August 31, 2010 - 6:49pm
tags:
off-label, FDA
What does your CEO think about Pharmaceutical Sales Representatives?
Pharmareform
Tuesday, August 31, 2010 - 5:43pm
tags:
Pharma CEOs, drug reps
Why Roche Employees Will Pay With Their Jobs for Cancer Drug Avastin’s Success
BNET Pharma
Tuesday, August 31, 2010 - 5:40pm
tags:
Roche, layoffs, Avastin, cancer
Genzyme for sale at right price, says CEO
Marketwatch
Tuesday, August 31, 2010 - 5:39pm
tags:
Genzyme, Henri Termeer, M&A, Sanofi
Catalyst for Pfizer and Bristol Expected in 2011
Minyanville
Tuesday, August 31, 2010 - 5:38pm
tags:
Pfizer, Bristol-Myers Squibb, Apixaban
J&J's Latest Recalls Cloud Outlook
TheStreet.com
Tuesday, August 31, 2010 - 1:05pm
tags:
recalls, DePuy, JNJ
Why Amgen Should Buy Genzyme
Forbes
Tuesday, August 31, 2010 - 1:03pm
tags:
Amgen, M&A, Genzyme, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.